FDA Considers Updating COVID-19 Vaccines

Live Chat

The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee meets from 8:30 a.m. to 5:00 p.m. ET on June 15 to discuss the “selection of a specific XBB lineage (e.g., XBB.1.5 or XBB.1.16 or XBB.2.3) for inclusion in the 2023-2024 Formula of COVID-19 vaccines in the United States.”

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.